Type 2 Diabetes: RO7795081 Study

We are investigating the safety of RO7795081, a new compound for type 2 diabetes and weight control. The study also looks at how this compound affects the processing of other approved medications in the body.

6-12 monthsSafety phase (I)DiabetologyEndocrinologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Pharma Bio-Research Group
Program Management
Groningen, Netherlands
Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.